Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawsuit Filed Over Gadolinium Toxicity Symptoms After MRI With Contrast November 5, 2018 Irvin Jackson Add Your Comments Following injections of MultHance and Omniscan, a product liability lawsuit indicates that the MRI contrast agents resulted in the development of painful and incurable gadolinium toxicity symptoms, including cognitive impairment, skin problems, bone and joint pain. In a complaint (PDF) filed in the U.S. District Court for the Eastern District of Louisiana on October 31, Judy Gomilla presents failure to warn claims against various manufacturers of gadolinium-based contrast agents; including Bracco Diagnostics, Bipso GMBH, Takeda GMBH, Acist Medical Systems, Inc., McKesson Corporation, Merry X-Ray Chemical Corporation, and GE Healthcare. Gomilla indicates that she received injections of MultiHance and Omniscan during MRI with contrast. The linear gadolinium contrast dyes are designed to help enhance the images, but the lawsuit indicates that Gomilla began to experience various symptoms of gadolinium toxicity shortly after receiving the injections. Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Gadolinium MRI Lawsuits Following an MRI with contrast, Gadolinium Deposition Disease may result in painful and debilitating problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although the gadolinium is supposed to be safely processed out of the body, Gomilla indicates that test results showed gadolinium retention in her body in December 2017, which she indicates accounts for the symptoms she has experienced. “Gadolinium is highly toxic. It does not occur naturally in the human body,” Gomilla’s lawsuit states. “The only pathway for gadolinium to have entered the plaintiff’s body was through injection during her MRI/MRA procedures.” Similar side effects have been reported among many individuals after undergoing an MRI with contrast. Increasingly referred to as gadolinium deposition disease (GDD), the symptoms can include persistent headaches, thickening of the skin, memory issues, cognitive problems and severe pain. Gomilla’s claim joins a growing number of MRI gadolinium toxicity lawsuits filed in recent months, each raising similar allegations that the manufacturers knew, or should have known, about the risks associated with their products, but failed to provide adequate warnings for patients or the medical community. MRI with Contrast Toxicity Problems Warnings about risks associated with gadolinium retention were previously issued for individuals with an acute kidney injury or chronic kidney disease about 10 years ago. However, gadolinium deposition disease is seen among patients with normal kidney function, who were not warned about the risk of these problems before agreeing to undergo an MRI with contrast. Several studies have found evidence that gadolinium from MRI contrast dyes may build up in the brain, leading the FDA to require more thorough research to help determine whether further restrictions need to be placed on the use of the contrast agents. In December 2017, the FDA issued a drug safety communication for Omniscan, Multihance and other gadolinium-based contrast agents, providing new information about the risk of gadolinium retention and potential side effects, even for individuals with normal kidney function. The manufacturers were required to provide new warnings and information in a Medication Guide, which all patients receiving an MRI contrast dye will be asked to read. The FDA also recommended that health care professionals consider the fact that the body retains gadolinium when deciding whether to give it to patients that may be at higher risk of health problems. These include women who are pregnant or think they may be pregnant, patients with kidney problems, children, and patients when inflammatory conditions. The recommendations also suggest that repeated use of the contrast agents be minimized where possible, particularly when MRIs are scheduled closely together. Patients are now urged to tell their health care professionals whether they are pregnant or may be pregnant, whether they have kidney problems, and the date of their last MRI with gadolinium, or whether they have had repeated MRI scans that involved the use of gadolinium contrast agents. As a growing number of individuals contact lawyers about gadolinium toxicity symptoms experienced following an MRI with contrast, the size of the litigation is expected to grow rapidly over the coming months and years. Tags: Gadolinium, Gadolinium Deposition Disease, GE Healthcare, MRI, MRI Contrast Agent, Multihance, Omniscan More Gadolinium Lawsuit Stories Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022 Gadolinium-Based MRI Contrast Agents Linked To Hypersensitivity Reactions: Study February 23, 2022 Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021 1 Comments Elaine April 10, 2019 Subject: Gadolinium and having only one kidney: My right kidney was surgically removed 6 years ago due to cancer. Three months ago I was given cortisone injections in my lower back, plus an I had an MRI where Gadolinium was injected as contrast. Since the date of those Gadoliniium accompanying those injections, my urine has changed dramatically from clear & odorless to dark, cloud and smelling strongly of an unknown chemical odor that makes me wonder if there is something wrong with my existing kidney, or other other parts of my urinary tract. My kidney doctor says she has never heard of a urine problem such as this. What kind of a doctor should I seek to address this odiferous problem with my urine? Each of several times I requested a urine evaluation, the lab comes back reporting: no bacterial infection. Any ideas? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
Using Gadolinium Contrast Dye with Epidural Steroid Injections Linked to “Terrible” Side Effects: Study November 15, 2022
Recent Strokes May Increase Gadolinium Brain Deposition Following MRI with Contrast: Study February 12, 2021
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)